Coronavirus: WHO gains access to nearly 2 billion doses of several ‘promising’ vaccine candidates

• ‘This is a time for taking comfort that the end of the pandemic is in sight, but taking care that we do not let down our guard,’ said WHO director general
• The arrangements include British-Swedish AstraZeneca, US-based Johnson & Johnson and the Serum Institute of India